Stereotaxis

STXSNYSE United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$139.066 M

$1.42 +4.41%

Close of 7 Aug 2026

Revenue

$32.4M

#2873 by revenue

Earnings

-$21.6M

Loss-making

Shares outstanding

97,736,700

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus — ranked by market cap

All 28 →

#11ElectromedELMD$349.3M
#12Edap TmsFOCL$233.2M
#13StereotaxisSTXS$139.1M
#14Vivani MedicalVANI$121.6M
#15SolanaHSDT$98.7M

Where these numbers come from

Share counts and financials for Stereotaxis are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.